Literature DB >> 7011614

Immune deposits in extraglomerular vessels: their correlation with circulating immune complexes.

R P Burden, R E Cotton, T B Wallington, W G Reeves.   

Abstract

Sixty-eight per cent of a consecutive series of 65 renal biopsies showed immune deposits in extraglomerular blood vessels. Although they occurred with a variety of clinical disorders and histological diagnoses, they were associated in particular with an acute nephritic syndrome, focal proliferative glomerulonephritis and non-specific mesangial changes. IgM was the commonest immunoglobulin class to be deposited and higher levels of IgM-containing complexes were detected in the serum of those patients with vascular deposits. Hitherto, immunofluorescent studies of renal biopsies have concentrated mostly on glomeruli but this study suggests that the extraglomerular vasculature deserves closer attention. The mechanisms for this pattern of localization are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7011614      PMCID: PMC1537151     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

Review 2.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

4.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

5.  Glutaraldehyde, cyanuric chloride and tetrazotized O-dianisidine as coupling reagents in the passive hemagglutination test.

Authors:  S Avrameas; B Taudou; S Chuilon
Journal:  Immunochemistry       Date:  1969-01

6.  Value of immune-complex assays in diagnosis and management.

Authors:  B A Pussell; C M Lockwood; D M Scott; A J Pinching; D K Peters
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

7.  Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.

Authors:  M Scullion; G Balint; K Whaley
Journal:  J Clin Lab Immunol       Date:  1979-04

8.  Extraglomerular immunoglobulin deposits in human nephritis.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

9.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits.

Authors:  F G Germuth; E Rodriguez; C A Lorelle; E I Trump; L L Milano; O Wise
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

View more
  3 in total

1.  Neutrophil function in chronic liver disease.

Authors:  A C Campbell; M W Dronfield; P J Toghill; W G Reeves
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

Review 2.  Vectored antibody gene delivery for the prevention or treatment of HIV infection.

Authors:  Cailin E Deal; Alejandro B Balazs
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

3.  Circulating immune complexes in cutaneous and systemic vasculitis: clinicopathological correlations.

Authors:  J Barratt; M Sindrey; R Summerly; G M Aber; P Naish
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.